GLAXOSMITHKLINE PHARMACEUTICALS
Back to Cashflow Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-737 Cr | ₹-769 Cr | ₹-561 Cr | ₹-1,543 Cr | ₹-524 Cr |
What is the latest Cash Flow from Financing Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-737 Cr |
| Mar2025 | ₹-769 Cr |
| Mar2024 | ₹-561 Cr |
| Mar2023 | ₹-1,543 Cr |
| Mar2022 | ₹-524 Cr |
How is Cash Flow from Financing Activities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-737 Cr | Negative | |
| Mar2025 | ₹-769 Cr | Negative | |
| Mar2024 | ₹-561 Cr | Negative | |
| Mar2023 | ₹-1,543 Cr | Negative | |
| Mar2022 | ₹-524 Cr | - | |
Compare Cash Flow from Financing Activities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹43,009.8 Cr | -0.1% | -4.1% | -4.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,474.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,989.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -0.1% |
-4.1% |
-4.7% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses